Inventory decreased 41.5%
Inventory changed -41.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory changed -41.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Revenue changed +26.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Net income changed -82.5% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating cash flow changed -63.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Shares outstanding changed -7.0% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Operating income changed +79.5% from the comparable as-filed period.
Current assets changed -4.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current liabilities changed +27.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Inventory / revenue changed -4094 basis points from the comparable as-filed period.
Operating margin changed +116 basis points from the comparable as-filed period.
Working capital / assets changed -518 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Receivables / revenue changed -1022 basis points from the comparable as-filed period.
Operating cash-flow margin changed -1358 basis points from the comparable as-filed period.
Operating cash flow / net income changed +110.2% from the comparable as-filed period.
Current ratio changed -24.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Trade receivables changed +13.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Working capital changed -7.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Research & development changed -12.1% from the comparable as-filed period.
Cash & equivalents changed +3.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
SBC / revenue changed -41 basis points from the comparable as-filed period.
R&D / revenue changed -105 basis points from the comparable as-filed period.
Stock-based compensation changed -5.3% from the comparable as-filed period.
Total assets changed -0.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.